Mass Spectrometry and Molecular Identity: What the Data Can Show

Mass spectrometry (MS) is an analytical technique that measures the mass-to-charge ratios of detected ions. It can provide valuable evidence about molecular identity, but the strength of an identity conclusion depends on the experiment, the instrument, the material and the interpretation of the observed signals.

Intact mass is a useful clue—not a complete structural proof

An accurate measured mass consistent with a candidate molecule may support a proposed identity. Yet more than one structure can share the same elemental composition and mass. Isomers, unresolved mixtures, adduct formation, oxidation, modifications, and the instrument's resolution can complicate interpretation. An isolated peak that matches an expected mass is not automatically proof of a unique amino-acid sequence.

What tandem mass spectrometry adds

In MS/MS experiments, selected ions are fragmented, and the resulting patterns can be compared with expected peptide fragments, spectral libraries, or sequence-generation algorithms. Fragment evidence can provide more discriminatory information than intact mass alone. However, interpretation depends on fragmentation coverage, spectrum quality, acquisition settings, and the assumptions of the search or inference method.

What should be included in an identity claim?

A scientifically useful report may identify the sample and lot; describe instrument and method; give the measured mass and uncertainty or tolerance; state which ion species was measured; and explain the comparison standard or sequence-matching strategy. Chromatographic separation, reference-standard matching, and orthogonal measurements may strengthen confidence where the scientific question requires them. The necessary evidence is specific to the analyte and intended application.

Identity, purity, and amount remain separate

MS evidence supporting the presence of a target analyte does not, by itself, determine the total mass of that material in a vial. It also does not establish that the sample is free of impurities or contaminants beyond the method's detection capability. An assay, an appropriate impurity method, and other tests may be needed to address those different claims.

Critical reading checklist

  • Is the report describing intact-mass agreement, fragment-based sequence support, or both?
  • Are the mass tolerance and potential adducts or modifications considered?
  • Is a reference standard or an independently documented interpretation method identified?
  • Does the sequence assignment acknowledge possible ambiguities or incomplete coverage?
  • Does the report distinguish sample identification from claims about safety or intended use?

For broader context on documentation, see How to Read a Certificate of Analysis (COA). This article is informational and does not assess or validate any particular supplier's testing.

References

  1. Ng, Zhou & Yao (2023), review of de novo peptide sequencing by tandem mass spectrometry
  2. Review: Protein identification by tandem mass spectrometry and database searching
  3. FDA / ICH Q2(R2): Validation of Analytical Procedures (2024)